DD237114A5 - Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung - Google Patents

Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD237114A5
DD237114A5 DD85276559A DD27655985A DD237114A5 DD 237114 A5 DD237114 A5 DD 237114A5 DD 85276559 A DD85276559 A DD 85276559A DD 27655985 A DD27655985 A DD 27655985A DD 237114 A5 DD237114 A5 DD 237114A5
Authority
DD
German Democratic Republic
Prior art keywords
nifedipine
weight
preparation
blocker
item
Prior art date
Application number
DD85276559A
Other languages
German (de)
English (en)
Inventor
Ulrich Posanski
Philippe O Lejeune
Eduard Porges
Klaus-Dieter Raemsch
Ahmed Hegasy
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD237114A5 publication Critical patent/DD237114A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DD85276559A 1984-05-23 1985-05-21 Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung DD237114A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843419130 DE3419130A1 (de) 1984-05-23 1984-05-23 Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD237114A5 true DD237114A5 (de) 1986-07-02

Family

ID=6236598

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85276559A DD237114A5 (de) 1984-05-23 1985-05-21 Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung

Country Status (14)

Country Link
EP (1) EP0165450A3 (xx)
JP (1) JPS60255724A (xx)
KR (1) KR850008619A (xx)
CN (1) CN85101820A (xx)
AU (1) AU4280785A (xx)
DD (1) DD237114A5 (xx)
DE (1) DE3419130A1 (xx)
DK (1) DK228085A (xx)
ES (1) ES8607725A1 (xx)
GR (1) GR851218B (xx)
HU (1) HUT38252A (xx)
IL (1) IL75244A0 (xx)
PT (1) PT80500B (xx)
ZA (1) ZA853878B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel
FR2577802B1 (fr) * 1985-02-26 1987-07-24 Synthelabo Compositions pharmaceutiques a base de betaxolol et de nifedipine
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
DE3829398A1 (de) * 1988-08-30 1990-03-08 Rentschler Arzneimittel Fixe arzneimittelkombination mit verzoegerter freisetzung
WO1993000081A1 (en) * 1991-06-28 1993-01-07 Sepracor, Inc. Optically pure s(-) nadolol for treatment of cardiovascular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (xx) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.

Also Published As

Publication number Publication date
ZA853878B (en) 1986-01-29
ES8607725A1 (es) 1986-06-01
AU4280785A (en) 1985-11-28
EP0165450A2 (de) 1985-12-27
ES543389A0 (es) 1986-06-01
CN85101820A (zh) 1987-01-10
PT80500A (en) 1985-06-01
PT80500B (en) 1987-04-21
HUT38252A (en) 1986-05-28
DE3419130A1 (de) 1985-11-28
EP0165450A3 (de) 1986-03-12
DK228085D0 (da) 1985-05-22
IL75244A0 (en) 1985-09-29
KR850008619A (ko) 1985-12-21
DK228085A (da) 1985-11-24
JPS60255724A (ja) 1985-12-17
GR851218B (xx) 1985-11-25

Similar Documents

Publication Publication Date Title
EP0078430B1 (de) Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
DE69311395T2 (de) Sphäroidische Arzneimittelformulierung
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE3685927T2 (de) Vitamine enthaltende granule.
DE2636152C2 (de) Verfahren zur Herstellung von Dragees
DE69305069T2 (de) Zusammensetzung für orale zubereitungen
DE69720995T2 (de) Granulate für die vorbereitung von schnellzerfallende und schnelllösendezubereitungen mit hohem anteil an wirkstoff
EP0126379B1 (de) Zweiphasenformulierung
CH659467A5 (de) Verfahren zur herstellung von nifedipin-trockenpraeparaten.
DE69620220T2 (de) Antibakterielles mittel zur oralen verabreichung
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE60036014T2 (de) Methode zur stabilisierung von benzimidazol-verbindungen
DE20218068U1 (de) Arzneimittel
DE60002570T2 (de) Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein
DD235183A5 (de) Verfahren zur herstellung von dihydropyridinpraeparaten
DE69209764T2 (de) Geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
DE3142853C2 (xx)
DD237114A5 (de) Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
DE2259646C2 (de) Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
DD236453A5 (de) Verfahren zur herstellung von nifedinpraeparaten
EP0116358B1 (de) Komplexe von Prostaglandinen
DE69330392T2 (de) Cytarabine Ocfosfate enthaltende harte Kapsel
DD249186A1 (de) Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit